As of April 13, 2026, Asian Phytoceuticals PCL (APCO.BK) reports a Current Ratio of 10.85.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Asian Phytoceuticals PCL's Current Ratio
Over recent years, Asian Phytoceuticals PCL's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2025-12-31 | 10.85 |
| 2024-12-31 | 10.75 |
| 2023-12-31 | 6.51 |
| 2022-12-31 | 5.27 |
| 2021-12-31 | 4.84 |
This steady improvement highlights how Asian Phytoceuticals PCL manages its short-term assets and liabilities over time.
Comparing Asian Phytoceuticals PCL's Current Ratio to Peers
To better understand Asian Phytoceuticals PCL's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Asian Phytoceuticals PCL (APCO.BK) | 10.85 |
| Radix Industries (India) Ltd (531412.BO) | 155.08 |
| Do Day Dream PCL (DDD.BK) | 20.63 |
| Pharmsville Co Ltd (318010.KQ) | 19.04 |
| Nova Wellness Group Bhd (NOVA.KL) | 17.57 |
| Cupid Ltd (CUPID.NS) | 13.30 |
Compared to its competitors, Asian Phytoceuticals PCL's Current Ratio is among the highest compared to peers, indicating strong short-term financial flexibility but potentially excess cash that could be invested.